2026 BD opportunity scan for CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals

2026 BD opportunity scan for Crystalys Therapeutics: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for CoRegen, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Convalife (Shanghai) Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rational

2026 BD opportunity scan for Connext Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Colgate-Palmolive Co.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Chongqing Precision Biotechnology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and out

2026 BD opportunity scan for Chongqing Paijin Biotechnology Co Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach

2026 BD opportunity scan for Chongqing Hilan Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea

2026 BD opportunity scan for Chongqing Chenan Biopharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou

2026 BD opportunity scan for China Resources Double-Crane Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signa

2026 BD opportunity scan for CHIESI Farmaceutici SpA: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.